16 Aug How to Assess Herbal Extract Standardisation
A botanical extract described as “standardised to 5%” may look straightforward on a product specification. It is not. To understand how to assess herbal extract standardisation, buyers need to establish what the percentage represents, how it was measured, whether it is relevant to the intended application, and how consistently it is controlled from batch to batch.
For formulators and procurement teams, standardisation is a practical quality and commercial issue. It affects dosage calculations, label claims, sensory performance, formulation stability, regulatory files and the ability to source equivalent material over time. A percentage alone is not a quality verdict.
What herbal extract standardisation actually means
Herbal extract standardisation is the process of producing and verifying an extract against defined compositional criteria. Usually, this means controlling a specified level of one or more marker compounds, active constituents or compound groups. Examples include curcuminoids in turmeric extract, ginsenosides in ginseng, silymarin in milk thistle, and polyphenols in green tea.
The term can be used too loosely. A properly standardised ingredient should have an agreed specification, a suitable analytical method and batch-specific evidence that the material meets that specification. It should also be tied to the correct botanical species and plant part. A 10% extract from the wrong species, or from leaves rather than roots, is not interchangeable simply because the assay number appears comparable.
Standardisation also does not mean that every naturally occurring compound is fixed at exactly the same level. Plants respond to geography, harvest timing, weather, cultivar and post-harvest handling. The purpose is to manage meaningful variation within an agreed range, not to imply that every batch has an identical full phytochemical profile.
Start with botanical identity and plant material
Before reviewing the assay, confirm the material being extracted. The specification should state the accepted Latin binomial, botanical authority where applicable, common name, plant part and, where relevant, the extraction solvent or solvent system.
This level of detail matters. Panax ginseng and Panax quinquefolius have different constituent profiles. Likewise, a root extract and an aerial-part extract from the same species may have materially different chemistry. Common names are not sufficient for purchasing specifications, especially where similar or substituted species are established in international trade.
Ask how identity is verified. Macroscopic and microscopic examination may be appropriate for raw herbs, while chromatographic fingerprinting, DNA-based methods or other orthogonal techniques may be more useful for processed botanical materials. No single approach suits every extract. Highly processed extracts can present limitations for DNA testing, while a chromatographic fingerprint may provide better evidence of compositional consistency.
Assess the marker, not just the percentage
The central question is: what is being standardised?
A marker may be a recognised bioactive constituent, a characteristic constituent used to confirm identity, or an analytical target selected mainly for process control. These categories should not be treated as equivalent. A high percentage of a convenient marker does not automatically indicate superior efficacy or a broader representation of the source herb.
For example, an extract standardised to total polyphenols may be useful where a broad polyphenol specification suits the formulation. However, total polyphenol assays can be less selective than targeted chromatographic methods and may not distinguish individual constituents. Where a product concept depends on a specific constituent group, a more defined assay is generally more useful.
Buyers should establish whether the marker is relevant to the intended claim, dosage rationale and product format. If the formulation is built around curcuminoids, the specification should identify total curcuminoids and ideally the analytical approach used. If a botanical has a recognised profile of several key compounds, an individual-component or fingerprint requirement may be more meaningful than one headline number.
Marker selection is therefore a balance. A narrow specification can improve control of a critical constituent but may encourage an extract profile that is less representative of the whole plant. A broader standard can better reflect the botanical matrix but may provide less precision for a targeted formulation.
Review assay method and basis of result
A certificate of analysis should state the test result, specification limit, method and result basis. Without this information, comparison between suppliers is unreliable.
HPLC or UHPLC methods are widely used for specific small-molecule markers because they offer selectivity and quantitative detail. GC methods may be appropriate for volatile constituents. UV-visible, gravimetric and titrimetric methods can be suitable for certain constituent groups, but they require careful interpretation because their specificity varies.
The assay basis is equally material. Check whether the declared result is calculated on an as-is basis, dry basis or another defined basis. Moisture can significantly affect the apparent percentage. An extract at 95% curcuminoids on a dry basis is not directly comparable with one declared as 95% as-is if their moisture levels differ.
Also verify whether the result is expressed as the named compound, as an equivalent, or as a compound group. “Total flavonoids” may be reported using a reference standard equivalent, which is not identical to a direct assay of each flavonoid present. The specification should make this clear.
Distinguish extract ratio from standardisation
A native extract ratio, such as 10:1, describes the relationship between the starting botanical material and the finished extract. It does not confirm an active-compound concentration. The ratio may be useful context, but it cannot replace an assay.
Ratios can also be difficult to compare where extraction yield, starting material quality or carrier content differ. A 10:1 extract is not inherently stronger than a 5:1 extract. For procurement and formulation purposes, a defined marker assay usually provides a more practical basis for comparing potency.
Where a carrier is used, such as maltodextrin, gum acacia or another permitted processing aid, it should be declared. Carrier content affects active concentration, flow properties, solubility and dose calculations. It may also affect whether two apparently similar extracts can be substituted without reformulation.
Calculate what the specification means at finished-product level
Translate the assay into the delivered amount per serving. If a capsule contains 500 mg of an extract standardised to 20% marker content, the nominal marker delivery is 100 mg per capsule. This calculation is simple, but it should use the lower specification limit rather than the typical result when setting guaranteed label values.
For example, if the supplier specification is 20.0% minimum but routine batches test at 24%, formulation calculations should normally be based on 20.0%. This protects the finished-product claim if later conforming batches sit closer to the lower limit.
Consider overages carefully. They may be necessary where a marker is known to decline during processing or shelf life, but an arbitrary overage can create cost, taste, colour or regulatory complications. Stability evidence for the extract in the intended dosage form is more useful than relying on a generic overage policy.
Check batch consistency and the wider specification
One compliant certificate of analysis demonstrates only one batch. Ask for representative historical data or several recent certificates where the purchase volume, claim sensitivity or ingredient risk justifies it. Look for realistic control around the target specification, not simply occasional high assay results.
The wider quality specification should cover parameters appropriate to the botanical and market. These commonly include identity, appearance, moisture or loss on drying, particle size where relevant, microbiological limits, heavy metals, pesticide residues, residual solvents, mycotoxins and foreign matter. The required panel depends on the herb, origin, extraction process and intended use.
A strong standardisation programme cannot compensate for weak contaminant control. A high-assay extract may still be unsuitable if it fails agreed microbiological, pesticide or heavy-metal limits. This is particularly relevant for materials sourced from regions with variable agricultural controls or for botanicals prone to mould-related contamination.
Examine the process behind the result
Ask whether the extract has been concentrated, purified, blended or fortified to meet its declared assay. These approaches are not automatically problematic. Purified extracts may be appropriate where a high and tightly defined constituent level is required. The commercial and technical issue is transparency.
The specification should describe the ingredient accurately. If isolated compounds have been added, or if batches are blended to achieve a target concentration, this should be known before the material is approved for a formulation. It can influence label wording, product positioning, analytical verification and equivalence to previously used material.
Extraction solvent is another decision point. Water, ethanol and hydroalcoholic systems can yield different constituent profiles. The preferred solvent depends on the botanical, desired markers, application and market requirements. For solvent-extracted materials, residual solvent testing must align with the agreed specification and applicable limits.
Build standardisation into supplier approval
Herbal extract standardisation should sit within a documented supplier-approval process rather than being assessed from a sales specification alone. Review the technical data sheet, certificate of analysis, allergen statement, GMO statement, origin information, safety documentation and relevant food-safety or quality-system credentials. For organic material, verify organic status and traceability through the applicable supply chain documentation.
For high-volume or technically sensitive projects, retain an approved reference sample and agree a change-control process. Changes to botanical origin, plant part, extraction solvent, carrier, assay method or specification range can alter finished-product performance even when the ingredient name remains unchanged.
At Nutra Ingredients Ltd., this type of documentation-led assessment supports trade buyers who need ingredients that can move from sample approval to repeat supply with clear technical control.
The most useful question is not whether an extract carries a standardisation percentage. It is whether the stated standard is botanically valid, analytically credible, appropriate for the formulation and consistently supported by batch documentation. When those points are clear before purchase, the ingredient is far more likely to perform as expected on the production floor and throughout its shelf life.